Vitalhub Corp. (TSE:VHI) Receives Consensus Rating of “Buy” from Brokerages

Shares of Vitalhub Corp. (TSE:VHI) have received a consensus recommendation of “Buy” from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is C$13.14.

VHI has been the subject of a number of research analyst reports. Raymond James Financial decreased their price target on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research note on Tuesday, March 24th. National Bank Financial reduced their target price on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 27th.

Vitalhub Price Performance

Vitalhub stock opened at C$7.10 on Monday. Vitalhub has a 1-year low of C$6.62 and a 1-year high of C$14.64. The firm has a market capitalization of C$449.15 million, a P/E ratio of 59.17, a price-to-earnings-growth ratio of 1.18 and a beta of 0.91. The company’s 50-day moving average is C$7.23 and its 200 day moving average is C$7.79.

Vitalhub (TSE:VHI) last announced its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 earnings per share (EPS) for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. The business had revenue of C$31.91 million during the quarter. Research analysts anticipate that Vitalhub will post 0.2296467 earnings per share for the current fiscal year.

Insider Activity at Vitalhub

In other news, Director Steve Garrington sold 10,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of C$7.17, for a total value of C$71,700.00. Following the transaction, the director directly owned 50,000 shares in the company, valued at approximately C$358,500. This represents a 16.67% decrease in their ownership of the stock. Insiders own 18.57% of the company’s stock.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.